{
  "id": "cluster_4_doc2",
  "content": "Policy update 230445-BSH regarding neurodegenerative disorders takes effect November 15, 2023. Covers advanced diagnostic imaging and antisense oligonucleotide therapies for prion diseases under prior authorization. Special provisions apply for patients enrolled in UCSF study GN1209. Claims department contacts: Maria Torres (415) 555-0198 for inquiries, documents to be routed to neurocare@blueshieldca.com. Implementation coincides with affected employee support program at tech companies.",
  "metadata": {
    "format": "policy_document"
  }
}